Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Theranostics 2021; 11(1):194-208. doi:10.7150/thno.44979 This issue Cite

Research Paper

Intravital molecular imaging reveals the restrained capacity of CTLs in the killing of tumor cells in the liver

Lei Liu1,2, Bolei Dai1,2, Ruixue Li1,2, Zheng Liu1,2, Zhihong Zhang1,2✉

1. Britton Chance Center for Biomedical Photonics, Wuhan National Laboratory for Optoelectronics-Huazhong University of Science and Technology, Wuhan, Hubei 430074, China.
2. MoE Key Laboratory for Biomedical Photonics, Collaborative Innovation Center for Biomedical Engineering, School of Engineering Sciences, Huazhong University of Science and Technology, Wuhan, Hubei 430074, China.

✉ Corresponding author: Zhihong Zhang, E-mail: czyzzhhust.edu.cn.

Citation:
Liu L, Dai B, Li R, Liu Z, Zhang Z. Intravital molecular imaging reveals the restrained capacity of CTLs in the killing of tumor cells in the liver. Theranostics 2021; 11(1):194-208. doi:10.7150/thno.44979. https://www.thno.org/v11p0194.htm
Other styles

File import instruction

Abstract

Graphic abstract

Cytotoxic T lymphocytes (CTLs) and their gene-engineered cells display great application prospects in tumor immunotherapy. The timing of CTL-induced molecular events in tumor cells is unclear, and we also unknow whether the killing efficiency of CTLs is restrained in the liver, an immunotolerant organ with a high tumor incidence.

Methods: We used intravital imaging to dynamically monitor the fluorescence resonance energy transfer (FRET) signals of caspase-3 and calcium sensor in tumor cells after transferring CTLs into tumor-bearing mice.

Results: Our data show that several CTLs attacked on one tumor cell, and on average each CTL killed 1.24 ± 0.11 tumor cells per day in the liver, which was much less efficient than that in the spleen (3.18 ± 0.26 tumor cells/CTL/day). The killing efficiency of CTLs is restrained in the liver and can be reversed by blocking immunosuppressive cytokine. Tumor cells exposed to CTLs appeared to have prolonged calcium influx, which occurred dozens of minutes before caspase-3 activity.

Conclusion: The quantitative characterization of these molecular and cellular events provides accurate information to evaluate the efficiency of cellular immunotherapy against tumors and understand the impact of an organ's immune status.

Keywords: molecular imaging, liver tumor, CTL, apoptosis, calcium signaling

Citation styles

APA
Liu, L., Dai, B., Li, R., Liu, Z., Zhang, Z. (2021). Intravital molecular imaging reveals the restrained capacity of CTLs in the killing of tumor cells in the liver. Theranostics, 11(1), 194-208. https://doi.org/10.7150/thno.44979.

ACS
Liu, L.; Dai, B.; Li, R.; Liu, Z.; Zhang, Z. Intravital molecular imaging reveals the restrained capacity of CTLs in the killing of tumor cells in the liver. Theranostics 2021, 11 (1), 194-208. DOI: 10.7150/thno.44979.

NLM
Liu L, Dai B, Li R, Liu Z, Zhang Z. Intravital molecular imaging reveals the restrained capacity of CTLs in the killing of tumor cells in the liver. Theranostics 2021; 11(1):194-208. doi:10.7150/thno.44979. https://www.thno.org/v11p0194.htm

CSE
Liu L, Dai B, Li R, Liu Z, Zhang Z. 2021. Intravital molecular imaging reveals the restrained capacity of CTLs in the killing of tumor cells in the liver. Theranostics. 11(1):194-208.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use